Back
NovaBay Pharmaceuticals, Inc. Vs. Apogee Enterprises, Inc. Industry Stock Comparison
Buy
85
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$19.26
Seasonality Move:
5.22%
Sell
48
APOG
Apogee Enterprises, Inc.
Last Price:
$35.37
Seasonality Move:
5.5%
Buy
85
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $19.16. The Score for NBY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
48
Apogee Enterprises, Inc. (APOG)
is a Sell
Is Apogee Enterprises, Inc. a Buy, Sell or Hold?
-
The current Apogee Enterprises, Inc. [APOG] share price is $35.35. The Score for APOG is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $19.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
APOG Stock Price Chart
What is Apogee Enterprises, Inc.'s stock price today?
-
The Apogee Enterprises, Inc. share price today is $35.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.66 | Buy |
| Relative Strength Index (14 RSI): | 88.54 | Buy |
| Chaikin Money Flow: | 9056672 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 8.68) | Buy |
| Bollinger Bands (100): | (-0.14 - 4.82) | Buy |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 43.66 | Sell |
| Chaikin Money Flow: | 274495 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.82 - 39.76) | Sell |
| Bollinger Bands (100): | (35.85 - 43.11) | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.76 | Buy |
| 20-day SMA: | 5.77 | Buy |
| 50-day SMA: | 2.97 | Buy |
| 200-day SMA: | 1.47 | Buy |
| 8-day EMA: | 10.07 | Buy |
| 20-day EMA: | 6.74 | Buy |
| 50-day EMA: | 4.01 | Buy |
| 200-day EMA: | 1.44 | Buy |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.71 | Sell |
| 20-day SMA: | 37.82 | Sell |
| 50-day SMA: | 36.57 | Sell |
| 200-day SMA: | 40.74 | Sell |
| 8-day EMA: | 35.62 | Sell |
| 20-day EMA: | 36.72 | Sell |
| 50-day EMA: | 37.48 | Sell |
| 200-day EMA: | 42.5 | Sell |
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Apogee Enterprises, Inc. Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.01 per share, a decrease this year of $1.50 per share, and a decrease next year of $0.29 per share.
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||